Navigation Links
Mylan Vice Chairman and CEO Robert J. Coury to Ring NYSE Closing Bell(R) in Celebration of Merck Generics Acquisition
Date:10/4/2007

PITTSBURGH, Oct. 4 /PRNewswire-FirstCall/ -- Mylan (NYSE: MYL) announced today that its Vice Chairman and CEO Robert J. Coury is scheduled to ring The Closing Bell(R) on the New York Stock Exchange (NYSE) at 4 p.m. today, Thursday, Oct. 4, 2007, in celebration of the Company's acquisition of Merck Generics. Mylan announced on Tuesday, October 2, that it had completed its acquisition of Merck KGaA's generics business to become one of the largest quality generics and specialty pharmaceuticals companies in the world.

When: Thursday, Oct. 4, 2007, 4 p.m.

Where: New York Stock Exchange, 11 Wall Street, New York City

A live webcast of The Closing Bell (beginning at 3:55 p.m.) will be available on the homepage of nyse.com.

About Mylan Inc.

Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The company offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ingredient (API) manufacturers in the world. Dey L.P., Mylan's fully integrated specialty business, provides the company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas. For more information about Mylan, please visit http://www.mylan.com.


'/>"/>
SOURCE Mylan Laboratories Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Mylan Wins Its Amlodipine Case With Pfizer
2. Mylan Announces Tentative FDA Approval for Its ANDA
3. Mylan Announces Final FDA Approval for Fluoxetine Capsules
4. Crohns Patient Robert Hill’s greatest achievemen
5. Relapse in Risk Management System Claims the Life of Robertson
6. Robert Wood Johnson Foundation Pledges $500M To Fund Anti-Obesity Programs
7. Ruling: HIV victim exempted from disclosing condition to partner
8. Closing in on Lethal Heart Rhythm in Young Athletes
9. Closing In On the Breast Cancer Gene
10. Brain Networks Strengthened by Closing Ion Channels
11. China Closing in on US for Highest Number of Web-users
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health ... partnership to prep patients for colonoscopy at the HyGIeaCare® Center that is to ... Miami, FL. , The HyGIeaCare® Prep, cleared by the U.S. Food ...
(Date:3/24/2017)... ... 2017 , ... “Finding Christ Through Social Media: Year One ... the writer’s path toward true communion with God. “Finding Christ Through Social Media: ... creation of published author Lea Michelle Johnson, a follower of Christ, wife and ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Communion of ... people of God in congregations across the United States. “The Communion of ... in 1964 who has served congregations in seven states throughout his long career ...
(Date:3/23/2017)... ... 23, 2017 , ... A recent report from the National Council on Teacher ... NCTQ report suggests, based on a review of GPA and SAT/ACT requirements at 221 ... the U.S. It argues that this higher bar should be set by states, by ...
(Date:3/23/2017)... ... March 23, 2017 , ... Texas Physical Therapy Specialists (TexPTS) ... Road in Building 2. The clinic is the group’s second in New Braunfels and ... the company’s second New Braunfels location brings things full circle for the group, “It’s ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , Latin America , and ... 2015 through 2022. Also, a six-year historic analysis is provided for these ...
(Date:3/24/2017)... , March 24, 2017  Eli Lilly ... announced plans to invest $850 million in its ... facilities across its U.S. enterprise, including research laboratories, ... investments are being driven by demand for Lilly ... potential medicines in development targeting cancer, pain, diabetes ...
(Date:3/24/2017)... , March 23, 2017  Mirabilis Medical, ... advanced medical technology for non-invasive surgery, announced today ... System for treatment of uterine fibroids throughout the ... had received approval from the US Food and ... the Mirabilis System in the United States.  The ...
Breaking Medicine Technology: